Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
---|---|---|---|
USD 16 Billion | USD 20 Billion | 6.01% | 2022 |
The global telepharmacy market size was evaluated at $16 billion in 2022 and is slated to hit $20 billion by the end of 2030 with a CAGR of nearly 6.01% between 2023 and 2030.
Telepharmacy is a term used for delivering pharmaceutical care to patients with the help of telecommunications in places where pharmacists reside in remote locations. It is a part of a wider telemedicine process implemented in the pharmacy domain. Moreover, telepharmacy services include patient counseling services, drug therapy monitoring services, prior authorization services, refilling authorization solutions for prescription drugs, and monitoring of formulary compliance with the help of teleconferencing as well as videoconferencing. Furthermore, telepharmacy solutions can be delivered at retail pharmacy locations through clinics, hospitals, nursing homes, and other healthcare establishments.
Rise in digitization in the telemedicine sector will spur global market trends over the coming years
Technological breakthroughs and growing digitization in a slew of telemedicine procedures will expedite the growth of the telepharmacy market across the globe. Surging web penetration and the rise in internet users globally along with the launching of 5G network leading to seamless network connectivity will spearhead the expansion of the market globally. An increase in the occurrence of chronic disorders and globalization along with thriving medical transcription activities will embellish the business sphere. With people preferring digital health services due to the rapid spread of viral infections such as COVID-19 along with the escalating need to reduce infectious, the market for telepharmacy is likely to gain traction in the years ahead. Growing need for telepharmacy in remote areas will drive global market trends. Moreover, new product launches and strategic partnerships are likely to boost the telepharmacy business globally in the upcoming years. For instance, in 2019, Pipeline Health Holdings LLC, a key community-based healthcare service provider based in the U.S., and YouScript Inc., a software firm based in the U.S., joined hands to expand their telepharmacy service portfolio. Such strategic moves will boost the growth of the market space in the coming years.
Low control on drug dispensing can impede the global industry expansion over 2023-2030
Lack of control on drug dispensing to the subjects can impede the expansion of the telepharmacy industry globally in the years ahead.
Rising demand for e-health services to avoid spread of viral infections can open new phase of growth for the global market
Growing preference for e-health solutions for preventing various kinds of viral infections such as COVID-19 is likely to open new growth avenues for the global telepharmacy market across the globe.
Stringent government regulations can pose a big threat to the global industry in the upcoming years
Strict government guidelines related to confidentiality and healthcare data protection have created a huge obstacle to the global telepharmacy industry expansion.
The global telepharmacy market is sectored into services, end-users, and region.
In service terms, the global telepharmacy market is segregated into remote order entry, pharmacy consultations, and others segments. Furthermore, the remote order entry segment, which amassed nearly 51% of the global market revenue share in 2022, is projected to record the highest CAGR in the forecasting timeline. The growth of the segment in the forecasting timespan can be subject to the humongous demand for remote order entry services by the patient residing in remote locations.
Based on the end-user, the global telepharmacy industry is sectored into primary care centers and hospitals segments. Furthermore, the hospitals segment, which garnered a major chunk of the global industry share in 2022, is projected to contribute lucratively towards the global industry expansion over the forecast period. The segmental growth over the assessment timeline can be subject to a plethora of benefits offered by telepharmacy services to hospitals. Citing an instance, the non-availability of pharmacists in hospitals in remote regions can transform into massive demand for telepharmacy services in these regions, thereby steering the expansion of the segment.
Report Attributes | Report Details |
---|---|
Report Name | Telepharmacy Market |
Market Size in 2022 | USD 16 Billion |
Market Forecast in 2030 | USD 20 Billion |
Growth Rate | CAGR of 6.01% |
Number of Pages | 214 |
Key Companies Covered | Telepharmacy Solutions Inc., North West TelePharmacy Solutions, Mitsui & Co. Inc., Medication Review Inc., Pipeline Health Holdings, McKesson Ventures, AMN Healthcare., and others. |
Segments Covered | By Services, By End-User, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2023 - 2030 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America is anticipated to maintain its global market leadership position over the expected timeline
North America, which contributed about three-fourths of the global telepharmacy market share in 2022, is expected to be a dominating region over the anticipated timeline. Furthermore, the regional market expansion can be ascribed to the rising need for remote patient surveillance, technological breakthroughs, and a surge in cases of chronic disorders. Favorable compensation policies and a rise in internet penetration are anticipated to boost the regional market trends. Furthermore, the surge in the per capita income of the population of Canada and the U.S. will proliferate the size of the market in the region. Presence of robust healthcare infrastructure facilities in the region will contribute sizably towards the growth of the telepharmacy business in the sub-continent.
The Asia-Pacific telepharmacy industry is anticipated to record the highest gains in the next couple of years due to a prominent demand for smartphones along with rising awareness about the benefits offered by telepharmacy to patients. Supportive government policies will further aid the expansion of the market in the region.
The global telepharmacy market profiles key players such as :
By Services
By End-User
FrequentlyAsked Questions
Telepharmacy is a term used for delivering pharmaceutical care to patients with the help of telecommunications in places where pharmacists reside in remote locations.
The global telepharmacy market growth can be owing to surging web penetration and a rise in internet users globally along with the launching of 5G network leading to seamless network connectivity.
According to a study, the global telepharmacy industry size was $16 billion in 2022 and is projected to reach $20 billion by the end of 2030.
The global telepharmacy market is anticipated to record a CAGR of nearly 6.01% from 2023 to 2030.
The Asia-Pacific telepharmacy industry is set to register the highest CAGR over the forecasting timeline owing to a prominent demand for smartphones along with rising awareness about the benefits offered by telepharmacy to patients. Supportive government policies will further aid the expansion of the market in the region.
The global telepharmacy market is led by players such as Telepharmacy Solutions, Inc., North West TelePharmacy Solutions, Mitsui & Co., Inc., Medication Review, Inc., Pipeline Health Holdings, McKesson Ventures, and AMN Healthcare.
The telepharmacy market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed